InnovAge Holding Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
InnovAge Holding wird ein jährliches Gewinn- und Umsatzwachstum von 123.8% bzw. 6.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 123.8% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 23% betragen.
Wichtige Informationen
123.8%
Wachstumsrate der Gewinne
123.77%
EPS-Wachstumsrate
| Healthcare Gewinnwachstum | 19.7% |
| Wachstumsrate der Einnahmen | 6.6% |
| Zukünftige Eigenkapitalrendite | 23.05% |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | 01 Jun 2026 |
Jüngste Aktualisierungen zum künftigen Wachstum
Analyseartikel • Feb 06
Earnings Beat: InnovAge Holding Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
InnovAge Holding Corp. ( NASDAQ:INNV ) investors will be delighted, with the company turning in some strong numbers...Analyseartikel • Nov 07
InnovAge Holding Corp. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
As you might know, InnovAge Holding Corp. ( NASDAQ:INNV ) just kicked off its latest quarterly results with some very...Recent updates
Narrativ-Update • Jun 19
INNV: Unchanged Assumptions And 2026 Guidance Will Restrain Stock Upside
Analysts have kept their fair value estimate for InnovAge Holding steady at $7.00 per share, reflecting largely unchanged assumptions for the discount rate, revenue growth, profit margin, and future P/E in their updated price target work. What’s in the News for InnovAge Holding InnovAge Holding issued updated corporate guidance for fiscal 2026, providing investors with a more detailed view of expected performance.Narrativ-Update • Jun 05
INNV: 2026 Guidance And Margin Outlook Will Shape Balanced Risk Reward
Analysts have kept their price target on InnovAge Holding steady at $7.00, pointing to slightly lower modeled revenue growth, a higher projected profit margin, and a modestly reduced future P/E assumption as key drivers of the updated view. What's in the News InnovAge Holding raised earnings guidance for fiscal 2026, with total revenues now expected in a range of US$950 million to US$975 million.Narrativ-Update • May 16
INNV: Updated Modeling And 2026 Guidance Will Shape Balanced Risk Reward Outlook
Analysts have raised their price target on InnovAge Holding to $7 from $5, reflecting updated modeling related to fair value, discount rate, growth expectations, profit margins, and future P/E assumptions. Analyst Commentary JPMorgan raised its price target on InnovAge Holding to US$7 from US$5 after updating its model, while maintaining an Underweight rating on the stock.Narrativ-Update • Apr 20
INNV: Updated Modeling And 2026 Guidance Will Likely Limit Future Share Upside
Analysts raised their price target on InnovAge Holding to $7 from $5, citing updated company modeling as the key driver of the change. Analyst Commentary The move to a US$7 price target signals that at least one major firm sees enough change in the underlying assumptions to justify a higher valuation for InnovAge Holding, even while keeping a cautious stance on the stock.Narrativ-Update • Apr 05
INNV: Updated Modeling And 2026 Guidance Will Likely Temper Upside Expectations
Analysts have raised their price target on InnovAge Holding to $7 from $5, reflecting updated modeling assumptions that incorporate refined views on fair value, discount rate, revenue growth, profit margin, and future P/E. Analyst Commentary JPMorgan's updated price target signals a fresh look at InnovAge Holding's valuation framework, even as the firm maintains an Underweight stance.Narrativ-Update • Mar 22
INNV: Raised Outlook And Model Assumptions Will Likely Prove Overly Optimistic
Analysts have lifted their price target on InnovAge Holding to $7 from $5, reflecting updated models that refine assumptions around fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Bullish Takeaways Bullish analysts view the lift in the price target to $7 as a sign that updated assumptions on fair value and discount rates support a higher implied equity valuation.Narrativ-Update • Mar 08
INNV: Raised Outlook And P/E Assumptions Will Likely Prove Overly Optimistic
Analysts have lifted their price target on InnovAge Holding to $7 from $5, reflecting updated modeling assumptions around fair value, discount rate, revenue growth, profit margin and future P/E that collectively support a modestly higher valuation framework. Analyst Commentary Bullish Takeaways Bullish analysts see the move to a US$7 price target as recognition that updated fair value work supports a somewhat higher valuation range than before.Seeking Alpha • Feb 23
InnovAge: The Headwinds Are Priced In, The Growth May Not Be
Summary InnovAge Holding Corp. delivers strong operational execution, driving significant revenue and margin expansion through its PACE model for elderly care. INNV’s revenue rose 14.7% year-over-year, fueled by participant growth and capitation rate adjustments across established centers. Disciplined cost management and SG&A reductions have expanded center-level contribution margin to 22% and adjusted EBITDA margin to 9.2%. Despite Medicaid eligibility headwinds, INNV’s improved processes and in-house pharmacy transition support a bullish outlook on sustainability and leverage. Read the full article on Seeking AlphaNarrativ-Update • Feb 21
INNV: Future Margin Assumptions Will Likely Prove Overly Optimistic
Analysts have revised their price target on InnovAge Holding, reflecting updated views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. Together, these factors result in a new target of $7.00, up from $5.00.Analyseartikel • Feb 06
Earnings Beat: InnovAge Holding Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
InnovAge Holding Corp. ( NASDAQ:INNV ) investors will be delighted, with the company turning in some strong numbers...Analyseartikel • Jan 17
InnovAge Holding Corp.'s (NASDAQ:INNV) Price In Tune With Revenues
It's not a stretch to say that InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 0.9x right...Analyseartikel • Dec 13
InnovAge Holding (NASDAQ:INNV) Might Be Having Difficulty Using Its Capital Effectively
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...Analyseartikel • Nov 07
InnovAge Holding Corp. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
As you might know, InnovAge Holding Corp. ( NASDAQ:INNV ) just kicked off its latest quarterly results with some very...Analyseartikel • Nov 03
Is InnovAge Holding (NASDAQ:INNV) A Risky Investment?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analyseartikel • Sep 10
Improved Revenues Required Before InnovAge Holding Corp. (NASDAQ:INNV) Stock's 32% Jump Looks Justified
InnovAge Holding Corp. ( NASDAQ:INNV ) shareholders would be excited to see that the share price has had a great month...Analyseartikel • Jul 08
Health Check: How Prudently Does InnovAge Holding (NASDAQ:INNV) Use Debt?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Neues Narrativ • May 29
Expanding US Senior Care Integration Will Drive Healthcare Transformation
Enrollment growth and efficient geographic expansion are positioning the company for sustained revenue gains and scalable growth.Analyseartikel • May 09
After Leaping 36% InnovAge Holding Corp. (NASDAQ:INNV) Shares Are Not Flying Under The Radar
InnovAge Holding Corp. ( NASDAQ:INNV ) shares have had a really impressive month, gaining 36% after a shaky period...Analyseartikel • Apr 09
Is InnovAge Holding (NASDAQ:INNV) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Analyseartikel • Feb 06
Investors Aren't Entirely Convinced By InnovAge Holding Corp.'s (NASDAQ:INNV) Revenues
InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 0.6x may look like a pretty appealing...Analyseartikel • Nov 07
Investors Aren't Entirely Convinced By InnovAge Holding Corp.'s (NASDAQ:INNV) Revenues
It's not a stretch to say that InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 1.1x seems...Analyseartikel • Aug 20
Is InnovAge Holding (NASDAQ:INNV) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analyseartikel • Jun 28
InnovAge Holding Corp.'s (NASDAQ:INNV) Shares Leap 30% Yet They're Still Not Telling The Full Story
InnovAge Holding Corp. ( NASDAQ:INNV ) shares have had a really impressive month, gaining 30% after a shaky period...Analyseartikel • May 07
Sentiment Still Eluding InnovAge Holding Corp. (NASDAQ:INNV)
It's not a stretch to say that InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 0.8x right...Analyseartikel • Mar 15
InnovAge Holding (NASDAQ:INNV) Has Debt But No Earnings; Should You Worry?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analyseartikel • Jan 06
Market Still Lacking Some Conviction On InnovAge Holding Corp. (NASDAQ:INNV)
There wouldn't be many who think InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 1.1x is...Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 6/30/2028 | 1,100 | 79 | 109 | 112 | 1 |
| 6/30/2027 | 1,034 | 57 | 87 | 92 | 3 |
| 6/30/2026 | 966 | -1 | 19 | 30 | 3 |
| 3/31/2026 | 949 | -12 | 43 | 52 | N/A |
| 12/31/2025 | 915 | 6 | 50 | 59 | N/A |
| 9/30/2025 | 885 | -17 | 36 | 44 | N/A |
| 6/30/2025 | 854 | -30 | 27 | 33 | N/A |
| 3/31/2025 | 832 | -31 | 16 | 26 | N/A |
| 12/31/2024 | 807 | -26 | -3 | 5 | N/A |
| 9/30/2024 | 787 | -16 | -19 | -11 | N/A |
| 6/30/2024 | 764 | -21 | -45 | -37 | N/A |
| 3/31/2024 | 741 | -31 | -34 | -26 | N/A |
| 12/31/2023 | 721 | -32 | -13 | 0 | N/A |
| 9/30/2023 | 699 | -38 | -44 | -26 | N/A |
| 6/30/2023 | 688 | -41 | -3 | 20 | N/A |
| 3/31/2023 | 684 | -42 | -26 | 10 | N/A |
| 12/31/2022 | 689 | -38 | -67 | -26 | N/A |
| 9/30/2022 | 697 | -27 | -23 | 20 | N/A |
| 6/30/2022 | 699 | -7 | -11 | 27 | N/A |
| 3/31/2022 | 697 | 13 | 9 | 34 | N/A |
| 12/31/2021 | 676 | 5 | 7 | 25 | N/A |
| 9/30/2021 | 658 | 13 | 13 | 31 | N/A |
| 6/30/2021 | 638 | -44 | -27 | -8 | N/A |
| 3/31/2021 | 619 | -38 | -12 | 7 | N/A |
| 12/31/2020 | 607 | -20 | 12 | 30 | N/A |
| 9/30/2020 | 585 | -26 | 6 | 19 | N/A |
| 6/30/2020 | 567 | 26 | 32 | 44 | N/A |
| 6/30/2019 | 466 | 20 | N/A | 26 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: INNV wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (3.5%).
Ertrag vs. Markt: INNV wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.
Hohe Wachstumserträge: INNV wird voraussichtlich in den nächsten 3 Jahren rentabel werden.
Einnahmen vs. Markt: INNVDie Einnahmen des Unternehmens (6.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (12.9% pro Jahr).
Hohe Wachstumseinnahmen: INNVDie Einnahmen des Unternehmens (6.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: INNVDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (23%)
Wachstumsunternehmen entdecken
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/07/09 06:59 |
| Aktienkurs zum Tagesende | 2026/07/09 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/06/30 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details des Analysemodells, das zur Erstellung dieses Berichts verwendet wurde, sind auf unserer GitHub-Seite verfügbar. Außerdem haben wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf YouTube.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
InnovAge Holding Corp. wird von 14 Analysten beobachtet. 3 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Vikram Kesavabhotla | Baird |
| Steven Valiquette | Barclays |
| Sarah James | Barclays |